US$ 21.27
glutathione iv ottawa push 69d198aa4cde4bbc2abae58b.webp
Description
Fan Gaskin et al., 2021)

BKM-120, PI3K Inhibitor, Demonstrates Acceptable Tolerability And Prelimary Activity In A Phase I/II Trial Of Patients With Advanced Leukemia's

Myo-inositol and selenium prevent subclinical hypothyroidism during pregnancy: An observational study

It is a chemotherapeutic agent against numerous breast cancer subtypes, including ER/PR-positive and triple-negative breast cancer [40]
